DONADINI, MARCO PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 4.400
EU - Europa 2.203
AS - Asia 458
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
SA - Sud America 1
Totale 7.072
Nazione #
US - Stati Uniti d'America 4.396
IT - Italia 1.203
UA - Ucraina 366
SE - Svezia 224
TR - Turchia 208
VN - Vietnam 126
DE - Germania 125
IE - Irlanda 125
CN - Cina 85
FI - Finlandia 62
GB - Regno Unito 52
IN - India 34
FR - Francia 23
NL - Olanda 10
AU - Australia 6
BE - Belgio 6
CA - Canada 4
PL - Polonia 3
AL - Albania 2
EU - Europa 2
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
EG - Egitto 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
LK - Sri Lanka 1
MY - Malesia 1
NZ - Nuova Zelanda 1
Totale 7.072
Città #
Milan 879
Fairfield 799
Woodbridge 497
Ashburn 370
Houston 351
Seattle 322
Chandler 280
Ann Arbor 270
Jacksonville 270
Wilmington 268
Cambridge 240
Izmir 126
Princeton 123
Dublin 122
Dearborn 92
Nyköping 87
Dong Ket 70
Rome 65
San Diego 47
Ogden 33
San Mateo 18
Como 14
Beijing 13
London 12
Düsseldorf 9
Varese 9
Washington 9
Chicago 8
Frankfurt am Main 8
Hefei 8
Kunming 8
Ralingen 8
Bangalore 7
Helsinki 7
Nanjing 7
Olgiate Olona 7
Redmond 7
Brussels 6
Norwalk 6
Redwood City 6
Verona 6
Los Angeles 5
Magnago 5
Nanchang 5
Venezia 5
Berlin 4
Boardman 4
Cagliari 4
Eppelborn 4
Falls Church 4
Fuzhou 4
Guangzhou 4
Wallersheim 4
Besana In Brianza 3
Detroit 3
Jinan 3
Nanning 3
Riccò Del Golfo 3
Toronto 3
Bologna 2
Chiswick 2
Esslingen am Neckar 2
Hounslow 2
Indiana 2
Islington 2
Mascalucia 2
Monza 2
Parabiago 2
Pescia 2
Phoenix 2
Pozzo d'Adda 2
Prescot 2
Pune 2
Quzhou 2
Shenyang 2
Trecate 2
Zabrze 2
Zhengzhou 2
Acton 1
Amsterdam 1
Augusta 1
Baghdad 1
Baltimore 1
Baotou 1
Bovisio Masciago 1
Cairo 1
Casorezzo 1
Changchun 1
Changsha 1
Clearwater 1
Colombo 1
Dillsboro 1
Duncan 1
Guangdong 1
Hamilton 1
Hangzhou 1
Hebei 1
Kilburn 1
Kuala Lumpur 1
La Spezia 1
Totale 5.624
Nome #
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis 233
Risk of recurrence of unusual site venous thromboembolism 211
Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients 195
Breadth of complications of long-term oral anticoagulant care 191
Optimal treatment duration of venous thrombosis 188
Patient selection for thromboprophylaxis in medical inpatients 184
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism. 176
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable? 176
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data 174
Treating patients with cancer and acute venous thromboembolism 169
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism 168
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study 160
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? 154
Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation 153
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs 153
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension. 152
Antidotes for the direct oral anticoagulants: What news? 146
Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study). 144
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies 138
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events 138
Pulmonary Embolism in Medical-Surgical Critically Ill Patients 137
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging. 133
Aspirin plus clopidogrel vs aspirin alone for preventing cardiovascular events among patients at high risk for cardiovascular events 132
Should alcohol be considered a minor protective factor for unprovoked venous thromboembolism? 130
Clinical approach to splanchnic vein thrombosis: Risk factors and treatment. 127
Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis. 126
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm 126
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis 124
Brand name versus generic warfarin: a systematic review of the literature. 124
Efficacy and safety of dabigatran etexilate: a narrative review 117
PL-19 splanchnic vein thrombosis: New risk factors and management 116
Retrievable vena cava filters: a clinical review. 116
Which patients with unprovoked VTE should receive extended anticoagulation? the minority. 113
Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations 113
null 109
Incidence of symptomatic and asymptomatic chronic pulmonary hypertension in patients with a previous episode of pulmonary embolism: a prospective cohort study 102
Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it? 101
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors 100
Prediction scores do not correlate with clinically adjudicated categories of pulmonary embolism in critically ill patients 99
Venous thromboembolism: pathophysiology, diagnosis and prophylaxis 94
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis 94
The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study. 90
Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts 81
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) 75
PROPOSAL FOR THE INCLUSION OF LOW MOLECULAR WEIGHT HEPARINS FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED PATIENTS IN THE WHO MODEL LIST OF ESSENTIAL MEDICINES 70
JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis 69
Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach 68
Unusual site thrombosis. 67
Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience 67
Splanchnic vein thrombosis 63
Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET) 61
Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review 60
Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound A Systematic Review and Meta-analysis 51
Perioperative Management of Patients who are Receiving Oral Anticoagulant Therapy 50
Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis 44
Manuale di emergenze medico-chirurgiche 44
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation 41
Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study 40
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. 38
Initial and Long-Term Treatment of Pulmonary Embolism: Current Approach and Future Perspectives 38
Trattamento del tromboembolismo venoso con anticoagulanti tradizionali e di nuova generazione. 37
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism 36
Anticoagulant treatment for Upper Extremity Deep Vein thrombosis: a systematic review and meta-analysis 33
Steps towards simplifying the treatment of pulmonary embolism 31
La trombosi venosa profonda e l’embolia polmonare 30
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? 15
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis 10
Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients 7
DOACs use in extreme body-weighted patients: results from the prospective START-register 5
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study 5
Development of personalized thrombogenesis and thrombin generation assays to assess endothelial dysfunction in cardiovascular diseases 4
Use of artificial intelligence and radiomics for risk stratification in patients with pulmonary embolism: New tools for an old problem 4
Factor XI inhibitors for the prevention of cardiovascular disease: A new therapeutic approach on the horizon? 3
Geographical and ethnoracial differences in venous thromboembolism and anticoagulation: An expanding horizon 3
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review 3
Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis 3
Venous and arterial thromboembolic risk of Janus kinase inhibitors: A systematic review with meta-analysis 1
Totale 7.183
Categoria #
all - tutte 23.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019388 0 0 0 0 0 0 0 0 0 0 155 233
2019/20201.491 53 64 63 227 108 178 230 194 164 98 22 90
2020/20211.610 21 222 178 129 126 215 131 90 171 75 114 138
2021/2022758 98 116 21 36 58 36 33 50 43 123 64 80
2022/2023760 78 64 28 96 57 158 10 84 123 26 19 17
2023/20241.418 244 234 227 274 278 60 2 27 60 8 4 0
Totale 7.183